CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Anthem BioSciences Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Anthem BioSciences Ltd
No 49 F1 & F2 CANARA BANK ROAD
Bommasandra Industrial Area Phase I
Phone: +91 8066724000p:+91 8066724000 BANGALORE, 560099  India Ticker: ANTHEMANTHEM
Business Summary
Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and much more. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its product line includes human nutrition, animal health, and industrial products. Under human nutrition, it offers active pharmaceutical ingredients, dietary supplements, probiotics, and enzymes, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
Yes--Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20253/31/2025Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2819 Industrial inorganic chemicals, not elsewhere classified
2869 Industrial organic chemicals, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer Mohammed G.Baig 4/1/2023 4/1/2023
Compliance Officer, Company Secretary DivyaPrasad 10/18/2024 10/18/2024
Managing Director AjayBhardwaj 63 6/13/2006 6/13/2006
6 additional Officers and Directors records available in full report.

Business Names
Business Name
ANTHEM
ANTHEM BIOSCIENCES PVT LTD

General Information
Number of Employees: 2,062 (As of 3/31/2025)
Outstanding Shares: 561,610,051 (As of 7/21/2025)
Stock Exchange: NSE
Email Address: bd@anthembio.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 25, 2025